Hi Folks,
Modular Medical (Nasdaq: MODD) has spent years developing a simpler approach to insulin-pump therapy.
Now, a key commercial catalyst is underway.
MODD is rolling its Pivot™ insulin pump into five targeted U.S. markets.
The Pivot™ tubeless insulin patch pump received FDA 510(k) clearance in April. First U.S. shipments followed in June, and MODD is now expanding its commercial rollout.
Starting in October, management plans to target Atlanta, Cincinnati/Lexington, Dallas, Houston and Philadelphia.
That's the development I'm watching.
MODD Targets a $3B Market
According to the company, roughly 4.8 million Americans require daily insulin, yet only about 20% use an insulin pump.
MODD is targeting adults who remain on multiple daily injections because existing pumps can present cost, complexity or usability barriers.
Management calls them "almost-pumpers" and estimates this addressable market at approximately $3B.
Pivot was designed with this group in mind, with a tubeless design intended to be easier to learn, use and afford.
There's experience behind Pivot, too. MODD founder Paul DiPerna previously founded the company that became Tandem Diabetes Care, which reported more than $1B in 2025 revenue.
Five Reasons MODD Is on My Radar
FDA Cleared: Pivot received FDA 510(k) clearance in April and entered U.S. commercial availability in June.
Five-Market Rollout: MODD plans to expand into five targeted markets beginning in October.
New FDA-Cleared Features: The FDA cleared additional software enhancements in September, including customizable bolus dosing and an updated interface.
National PBM Agreement: MODD announced an agreement with a major national pharmacy benefit manager, expanding Pivot's access through an established benefits channel.
More in the Pipeline: MODD is developing automated insulin delivery with Nudge BG while exploring its MODD1 platform for personalized GLP-1 therapy.
FDA clearance, a five-market rollout and several additional catalysts give investors plenty to watch as MODD moves into its next stage.
Pull up MODD on your trading screen and take a closer look.
To Your Success,
Kevin Vander
© 2026 10XProTrader.com All rights reserved. You are receiving this email as part of your subscription to 10XProTrader.com. Nothing in this e-mail should be considered personalized financial advice. We are neither a registered investment adviser nor a broker/dealer. Content provided is for informational, educational, and publishing purposes only. We are a financial publisher that does not offer any personal financial advice or advocate the purchase or sale of any security or investment for any specific individual. Pursuant to an agreement between 10XProTrader and STM LLC, 10XProTrader has been hired to publish and disseminate information about MODD starting on 10/14/26 and ending on 10/15/26. Under this agreement, STM LLC has paid 10XProTrader fifteen thousand USD. 10XProTrader owns no shares of MODD, maintains no position in MODD, and does not trade securities featured in its publications.